Barclays lowered the firm’s price target on Corebridge (CRBG) to $30 from $33 and keeps an Overweight rating on the shares. The firm adjusted targets in the insurance group as part of a Q1 preview. Premium growth and broker organic growth “are likely to remain sluggish,” the analyst tells investors in a research note. However, Barclays sees solid margins and strong capital deployment still contributing to reported book value growth in Q1.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBG:
- Midday Fly By: Corebridge to merge with Equitable
- Corebridge Financial, Inc. (CRBG) and Equitable Holdings (EQH) Stocks Jump on Merger Plans
- Video: Memory stocks slipping amid worries about Google compression technique
- Morning Movers: Kodiak Sciences skyrockets following GLOW2 study results
- Corebridge and Equitable Announce Transformational All-Stock Merger